![Øystein Rekdal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Øystein Rekdal
Amministratore Delegato presso
LYTIX BIOPHARMA ASA
Patrimonio netto: 201 262 $ in data 31/05/2026
Profilo
Øystein Rekdal is the founder of Lytix Biopharma AS, serving as Chief Executive Officer & Media Relations Contact since 2019, founded in 2003.
Dr. Rekdal is a Professor at the University of Tromso.
Formerly, Dr. Rekdal worked as Director at Prophylix AS.
Education includes a doctorate from the University of Tromso.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
LYTIX BIOPHARMA ASA 0,23% | 11/12/2025 | 176.179 ( 0,23% ) | 201 262 $ | 31/05/2026 |
Posizioni attive di Øystein Rekdal
| Società | Posizione | Inizio |
|---|---|---|
| LYTIX BIOPHARMA ASA | Amministratore Delegato | 11/09/2019 |
University of Tromso
 University of Tromso Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Precedenti posizioni note di Øystein Rekdal
| Società | Posizione | Fine |
|---|---|---|
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Provides prophylactic medicinal product for newborns | Direttore/Membro del Consiglio | - |
Formazione di Øystein Rekdal
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
17
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
University of Tromso
University of Tromso Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lytix Biopharma AS
 Lytix Biopharma AS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops novel cancer immunotherapies | Health Technology |
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Provides prophylactic medicinal product for newborns | Health Technology |
